|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-4-2
|
|
pubmed:abstractText |
Neoadjuvant (primary) chemotherapy is being used increasingly in the treatment of patients with large and locally advanced breast cancer with the aim of reducing the size of the primary tumor and eliminating micrometastatic disease. Response rates to, compliance with, and survival of patients following neoadjuvant chemotherapy have been variable. We report the results of a consecutive series of 77 patients with breast cancer who received neoadjuvant chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0002-9610
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
175
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
127-32
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:9515529-Adult,
pubmed-meshheading:9515529-Aged,
pubmed-meshheading:9515529-Aged, 80 and over,
pubmed-meshheading:9515529-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9515529-Breast Neoplasms,
pubmed-meshheading:9515529-Combined Modality Therapy,
pubmed-meshheading:9515529-Female,
pubmed-meshheading:9515529-Humans,
pubmed-meshheading:9515529-Middle Aged,
pubmed-meshheading:9515529-Neoplasm Staging,
pubmed-meshheading:9515529-Prognosis,
pubmed-meshheading:9515529-Proportional Hazards Models,
pubmed-meshheading:9515529-Survival Analysis
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy.
|
|
pubmed:affiliation |
Department of Surgery, University of Aberdeen, Scotland, United Kingdom.
|
|
pubmed:publicationType |
Journal Article
|
